July 2026

The Mysterious Headache That Starts One Day and Never Goes Away

Patients describe the onset with unusual precision. They remember the exact date, sometimes the exact hour. One day they were headache-free; the next day they had a headache that never left. Weeks pass, then months, then years, the pain persisting continuously from that initial moment. This is new daily persistent headache, one of neurology’s most puzzling and treatment-resistant conditions, affecting an unknown number of patients who often go years without proper diagnosis.

New Daily Persistent Headache (NDPH) defies the patterns clinicians expect. Most chronic headaches evolve gradually, episodic migraine slowly increasing in frequency, tension-type headache becoming more persistent over time. NDPH appears abruptly in people with no significant headache history, then refuses to remit. The discontinuity between before and after suggests a triggering event, but identifying that trigger often proves impossible.

The Diagnostic Challenge

Defining NDPH has proven contentious. The International Classification of Headache Disorders requires continuous headache from onset, remembered onset date, and absence of prior headache disorder that could explain the presentation. But these criteria leave substantial ambiguity about what NDPH actually is, whether it represents a single entity or a final common pathway for multiple different conditions.

The phenotype is heterogeneous. Some patients describe migraine-like features, throbbing pain, light sensitivity, nausea. Others report tension-type characteristics, pressing quality, bilateral distribution. Still others have mixed presentations that don’t fit neatly into established categories. This variability suggests NDPH may be a syndrome with multiple underlying causes rather than a single disease.

Triggering events are identified in approximately half of cases. Viral infections, particularly Epstein-Barr virus and other herpesviruses, precede many cases. Stressful life events, surgical procedures, and head trauma are reported in others. But the other half of patients recall no precipitant at all. The headache simply began, without apparent reason, and continued indefinitely.

“NDPH challenges our understanding of headache pathophysiology because it doesn’t follow the rules we’ve established for other headache disorders,” explains Rab Nawaz, M.D., a board-certified neurologist in the United Kingdom and expert contributor to MyMigraineTeam. “The abrupt onset suggests a triggering event, but we often can’t identify one. The persistence suggests ongoing pathology, but we usually can’t demonstrate it on imaging or testing. We’re left with a condition defined by what we observe clinically, daily headache from a specific start date, without clear understanding of what’s causing it or how to make it stop.”

The Treatment Resistance

NDPH’s reputation for treatment resistance is well-earned. Medications effective for migraine or tension-type headache often fail. Patients accumulate trials of preventives, beta-blockers, antidepressants, anticonvulsants, CGRP inhibitors, without meaningful improvement. Acute medications provide temporary relief but don’t address the underlying persistence.

The refractory nature may relate to central sensitization established early in the condition’s course. If the nervous system becomes sensitized during the initial weeks of continuous pain, subsequent treatments may struggle to reverse changes that have already become entrenched. Early aggressive treatment might theoretically prevent this sensitization, but most patients aren’t diagnosed quickly enough to test this hypothesis.

Some researchers have proposed NDPH subtypes with different prognoses. A “self-limiting” form may resolve spontaneously within months to years. A “refractory” form persists indefinitely despite treatment. Distinguishing these subtypes at onset would have obvious clinical value but currently isn’t possible.

“The treatment-resistant reputation of NDPH becomes somewhat self-fulfilling,” explains Dani Cabral. “Patients who respond to initial treatments may be reclassified as having had something else, chronic migraine that happened to start abruptly, perhaps. Those who don’t respond remain in the NDPH category, creating a cohort enriched for treatment failure. This selection bias may make NDPH appear more refractory than it actually is for the full spectrum of patients who initially present with the syndrome.”

The Viral Hypothesis

The association between NDPH and preceding viral infection has generated particular research interest. If viral infection can trigger persistent headache, understanding the mechanism might reveal treatment targets currently unaddressed.

Epstein-Barr virus has the most documented association with NDPH onset. Case series describe patients developing continuous headache during or shortly after infectious mononucleosis, with headache persisting long after the acute infection resolved. The virus’s neurotropism and ability to establish latent infection provide biological plausibility for prolonged effects.

COVID-19 has added new urgency to the viral hypothesis. Reports of NDPH following SARS-CoV-2 infection have accumulated since 2020. The broader phenomenon of long COVID, persistent symptoms following acute infection, provides a framework for understanding how viral illness might trigger chronic pain syndromes.

Proposed mechanisms include direct viral neuroinvasion, post-infectious autoimmunity targeting neural structures, and persistent inflammation disrupting pain modulation. None has been definitively established for NDPH specifically. The absence of consistently abnormal biomarkers or imaging findings leaves the pathophysiology frustratingly obscure.

The Diagnostic Workup

Secondary causes must be excluded before NDPH is diagnosed. Conditions that can present with persistent headache from identifiable onset, intracranial hypertension, cerebral venous thrombosis, CSF leak, infection, inflammation, require imaging and sometimes lumbar puncture to rule out.

MRI with and without contrast evaluates structural causes. MR venography assesses cerebral venous drainage. Opening pressure measurement during lumbar puncture identifies intracranial pressure abnormalities. CSF analysis screens for infection and inflammation. The workup is often extensive before the diagnosis of exclusion is reached.

Cervicogenic headache, pain referred from cervical spine pathology, deserves consideration when neck symptoms are present. Temporomandibular dysfunction can produce persistent head pain. Medication overuse headache can maintain continuous symptoms even from an abrupt initial onset. These potentially treatable conditions must be excluded before accepting NDPH’s implications of limited treatment options.

The Patient Experience

Living with NDPH imposes burdens beyond the physical pain. The diagnostic journey is often prolonged and frustrating, with patients seeing multiple providers before receiving a name for their condition. Even then, the diagnosis offers limited comfort, a label without clear treatment or prognosis.

The persistent nature affects every aspect of daily function. Unlike episodic conditions with pain-free intervals, NDPH offers no respite. Adaptation occurs to some degree, but continuous pain eventually depletes coping resources. Depression and anxiety are common comorbidities, though whether they’re causes, consequences, or both remains unclear.

Treatment-seeking can become its own burden. Accumulating medication trials, specialist consultations, and imaging studies consume time, money, and hope. Some patients eventually disengage from medical care, concluding that nothing will help. Others persist indefinitely, trying each new treatment that becomes available.

The condition’s obscurity compounds the isolation. Friends and family may doubt the reality of a headache that never ends. Disability systems are skeptical of conditions without objective findings. The patient occupies an uncertain space, clearly suffering, yet without the validated diagnosis and treatment pathway that other conditions provide.

NDPH represents a frontier of headache medicine where understanding remains limited and treatment options inadequate. Progress requires research investment in a condition affecting relatively few patients with heterogeneous presentations, a challenging proposition in a medical research economy that favors larger, better-defined populations.